Department of Epidemiology and Preventive Medicine, Infectious Disease Epidemiology Unit, Monash University, Melbourne, Australia.
J Clin Microbiol. 2013 Oct;51(10):3374-9. doi: 10.1128/JCM.01501-13. Epub 2013 Aug 7.
Contact precautions are recommended in hospitals to prevent the transmission of vancomycin-resistant enterococci (VRE); however, there is no clear policy for how long patients should be under contact precautions due to a lack of information on the duration of carriage of these organisms. We conducted a retrospective cohort study to understand the duration of carriage of VRE (by screening of a single stool culture) and associated factors among patients who had been identified with VRE infection and/or colonization since the year 2000 at our health facilities. Of the 345 eligible participants, 136 did not respond, 90 declined to participate, and 16 did not send in the required specimens. Of the 103 remaining participants, 13 were found to have current VRE fecal carriage. The proportion of colonized patients fell from 40% (2/5) in the first year to 23.3% (7/30) in year 4. None of the 40 patients who had VRE detected >4 years prior were found to be colonized at the time of the study. The longest duration of detected VRE positivity was 46.5 months. Univariate analysis revealed that recent exposure to any antibiotics (P = 0.016), multiple antibiotics (P = 0.001), amoxicillin-clavulanic acid (P = 0.021), piperacillin-tazobactam (P = 0.007), glycopeptides (P < 0.001), meropenem (P = 0.007), aminoglycosides (P = 0.021), or fluoroquinolones (P = 0.021), being the index case in a clinical specimen (P = 0.016), and recent hospitalization (P < 0.001) were significantly associated with continued carriage on follow-up. In the surviving outpatients, a significant proportion appeared to clear VRE carriage. Our results suggest that in the absence of recent risk factors, such as hospitalization or antibiotic use, patients with a remote history of colonization (>4 years) may no longer require contact isolation precautions.
接触预防措施被建议用于医院以预防耐万古霉素肠球菌(VRE)的传播;然而,由于缺乏关于这些生物体携带时间的信息,因此对于患者应接受接触预防措施的时间长短没有明确的政策。我们进行了一项回顾性队列研究,以了解自 2000 年以来在我们的医疗设施中被诊断为 VRE 感染和/或定植的患者中 VRE 的携带时间(通过单次粪便培养筛查)及其相关因素。在 345 名符合条件的参与者中,有 136 人未回复,90 人拒绝参与,16 人未提交所需标本。在剩余的 103 名参与者中,发现 13 人当前具有 VRE 粪便携带。定植患者的比例从第一年的 40%(2/5)下降到第四年的 23.3%(7/30)。在研究时,没有发现 4 年前检测到 VRE 的 40 名患者中有任何定植。检测到的 VRE 阳性持续时间最长为 46.5 个月。单变量分析显示,最近接触任何抗生素(P=0.016)、多种抗生素(P=0.001)、阿莫西林克拉维酸(P=0.021)、哌拉西林他唑巴坦(P=0.007)、糖肽类(P<0.001)、美罗培南(P=0.007)、氨基糖苷类(P=0.021)或氟喹诺酮类(P=0.021)、作为临床标本的索引病例(P=0.016)和最近住院(P<0.001)与随访时的持续携带显著相关。在幸存的门诊患者中,相当一部分似乎清除了 VRE 携带。我们的结果表明,在没有最近的危险因素(如住院或抗生素使用)的情况下,具有 >4 年定植史的患者可能不再需要接触隔离预防措施。